The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Dec. 20, 10:46 AM

Slide #19. Flexion Therapeutics, Inc. Secondary Offering

Company: Flexion Therapeutics, Inc. (NASDAQ:FLXN)
Date announced: 12/8/2014
Shares Offered: 5,040,000
Date of Pricing: 12/12/2014
Price Per Share: $17.00
Secondary Offering Details: Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it is offering to sell 3,500,000 shares of common stock in an underwritten public offering. Flexion also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock in the public offering. - updated 12/12 - Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the pricing of its underwritten public offering of 5,040,000 shares of common stock at a price to the public of $17.00 per share. Flexion has also granted the underwriters a 30-day option to purchase up to an additional 756,000 shares of common stock. The offering is expected to close on December 17, 2014, subject to customary closing conditions.

Flexion Therapeutics is a pharmaceutical company focused on the development and commercialization of injectable pain therapies. Co. is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis, and post-operative pain. Co.'s product candidate, FX006, is an injectable, sustained-release, intra-articular (IA), meaning in the joint, steroid treatment for patients with moderate to severe OA pain. Co.'s other product candidates include, FX007 for post-operative pain and FX005 for the treatment of end-stage OA patients.
Open the FLXN Page at The Online Investor »

Company Name:  Flexion Therapeutics, Inc.
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding FLXN:  12
Total Market Value Held by ETFs:  $2.66M
Total Market Capitalization:  $327.00M
% of Market Cap. Held by ETFs:  0.81%

Open the FLXN Page at The Online Investor (in a new window) »

December 20, 2014    10:46 AM Eastern
Quotes delayed 20 minutes

Strong Buy (3.75 out of 4)
82nd percentile
(ranked higher than approx. 82% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.